UK Markets close in 3 hrs 10 mins

LANXESS Aktiengesellschaft (0H7I.L)

YHD - YHD Delayed price. Currency in USD
Add to watchlist
7,202,999,808.00+31.18 (+0.00%)
At close: 6:07PM EDT
Full screen
Previous closeN/A
YTD returnN/A
Expense ratio (net)N/A
CategoryN/A
Last cap gainN/A
Morningstar ratingN/A
Morningstar risk ratingN/A
Sustainability rating
Net assetsN/A
Beta (5Y monthly)N/A
YieldN/A
5y average returnN/A
Holdings turnoverN/A
Last dividendN/A
Average for categoryN/A
Inception dateN/A
  • EQS Group

    LANXESS Aktiengesellschaft: LANXESS signs contract to acquire Emerald Kalama Chemical

    LANXESS Aktiengesellschaft / Key word(s): Mergers & Acquisitions/TakeoverLANXESS Aktiengesellschaft: LANXESS signs contract to acquire Emerald Kalama Chemical14-Feb-2021 / 00:42 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Ad hoc according to Art. 17 paragraph 1 MMVOLANXESS signs contract to acquire Emerald Kalama ChemicalCologne, February 14, 2021 - Specialty chemicals company LANXESS signed an agreement to acquire US-based Emerald Kalama Chemical from affiliates of American Securities LLC. Emerald Kalama Chemical is one of the leading global manufacturers of specialty chemicals especially for the consumer segment.Emerald Kalama employs worldwide approximately 500 employees and runs three production sites. The company reported 2020 sales of around USD 425 million and EBITDA pre exceptionals of approximately USD 90 million. Around 45 percent of its turnover is generated in North America.The enterprise value amounts to USD 1,075 million. The transaction will be financed by LANXESS existing liquidity. Closing of the transaction is anticipated in the second half of 2021 and subject to the approval of the relevant regulatory authorities.By acquiring Emerald Kalama Chemical, LANXESS strengthens its specialty chemical portfolio especially in the Consumer Protection segment and would materially expand into the growth markets food and animal nutrition.Cologne, February 14, 2021Forward-Looking StatementsThis company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.Contact:André SimonLANXESS AGHead of Investor RelationsKennedyplatz 150569 Köln, DeutschlandTelefon: +49 221 8885-3494Fax: +49 221 8885-4944E-Mail: andre.simon@lanxess.com14-Feb-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de Language: English Company: LANXESS Aktiengesellschaft Kennedyplatz 1 50569 Cologne Germany Phone: +49 (0)221 8885-3494 Fax: +49 (0)221 8885-4944 E-mail: ir@lanxess.com Internet: www.lanxess.com ISIN: DE0005470405 WKN: 547040 Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1167850 End of Announcement DGAP News Service

  • EQS Group

    LANXESS Aktiengesellschaft: EBITDA pre exceptionals for fourth quarter 2020 estimated above market expectations

    LANXESS Aktiengesellschaft / Key word(s): Preliminary Results/Quarter ResultsLANXESS Aktiengesellschaft: EBITDA pre exceptionals for fourth quarter 2020 estimated above market expectations26-Jan-2021 / 13:13 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Ad hoc according to Art. 17 paragraph 1 MMVOLANXESS Aktiengesellschaft: EBITDA pre exceptionals for fourth quarter 2020 estimated above market expectationsSpecialty chemicals company LANXESS expects to achieve fourth quarter 2020 EBITDA pre exceptionals that considerably exceeds average market expectations and previous year's level.EBITDA pre exceptionals for the fourth quarter 2020 is estimated to amount to EUR 200 million which exceeds average market expectations of EUR 181 million by 10 percent.The fourth quarter result was positively influenced by a stronger than expected increase in demand especially from the automotive industry particularly in the month of December. LANXESS supplies this industry mainly through its Engineering Materials segment. The segments Advanced Intermediates and Specialty Additives also recorded a business development above expectation.In the prior-year quarter, LANXESS EBITDA pre exceptionals reached EUR 197 million.LANXESS will release its final results for the fourth quarter 2020 and the fiscal year 2020 on March 11, 2021. All figures provided in this release are preliminary and unaudited.Cologne, 26 January 2021Contact:André SimonLANXESS AGHead of Investor RelationsKennedyplatz 150569 Köln, DeutschlandTelefon: +49 221 8885-3494Fax: +49 221 8885-4944E-Mail: andre.simon@lanxess.comForward-Looking StatementsThis company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.Information and Explanation of the Issuer to this News: 26-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de Language: English Company: LANXESS Aktiengesellschaft Kennedyplatz 1 50569 Cologne Germany Phone: +49 (0)221 8885-3494 Fax: +49 (0)221 8885-4944 E-mail: ir@lanxess.com Internet: www.lanxess.com ISIN: DE0005470405 WKN: 547040 Indices: MDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1163319 End of Announcement DGAP News Service

  • Brokers bullish on Lanxess Ag shares
    Stockopedia

    Brokers bullish on Lanxess Ag shares

    The Lanxess Ag (ETR:LXS) share price has risen by 1.69% over the past month and it’s currently trading at 49.2. For investors considering whether to buy, hold...